Bronchoalveolar lavage fluid D dimer levels are higher and more prevalent in black patients with pulmonary sarcoidosis

Respiration

Volumn 74, Issue 3, 2007, Pages 297-303

  Perez, Rafael L ^a,b   Kimani, Anthony P ^e   King Jr , Talmadge E ^c,d   Aguayo, Samuel M ^b   Roman, Jesse ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ATLANTA VA MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^e Kimani Clinic   (United States)

Author keywords

Bronchoalveolar lavage; D dimer; Fibrin; Interstitial lung disease; Sarcoidosis

Indexed keywords

D DIMER;

ADOLESCENT; ADULT; AFRICAN AMERICAN; AGE DISTRIBUTION; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; ENZYME IMMUNOASSAY; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LUNG LAVAGE; MAJOR CLINICAL STUDY; MALE; NEGRO; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; SARCOIDOSIS; STATISTICAL SIGNIFICANCE;

ADULT; AFRICAN AMERICANS; AGED; AUTORADIOGRAPHY; BIOLOGICAL MARKERS; BRONCHOALVEOLAR LAVAGE FLUID; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; HUMANS; LUNG; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SARCOIDOSIS, PULMONARY; STATISTICS, NONPARAMETRIC;

EID: 34249699667     PISSN: 00257931     EISSN: None     Source Type: Journal    
DOI: 10.1159/000091994     Document Type: Article

References (36)

1. Newman LS, Rose CS, Maier L: Sarcoidosis. N Engl J Med 1997;336:1224-1234.
2. Strieter RM: To clot or not to clot, that is the question in pulmonary fibrosis. Am J Respir Crit Care Med 2003;167:1589-1590.
3. Chapman HA, Allen CL, Stone OL: Abnormalities in pathways of alveolar fibrin turnover among patients with interstitial lung disease. Am Rev Respir Dis 1986;133:437-443.
4. Hasday JD, Bachwich PR, Lynch JP, Sitrin RG: Procoagulant and plasminogen activator activities of bronchoalveolar fluid in patients with pulmonary sarcoidosis. Exp Lung Res 1988;14:261-278.
5. Perez RL, Staton GW Jr, Kidd MR, Check IJ: Increased procoagulant activity of bronchoalveolar lavage cells in patients with sarcoidosis: relationship to steroid treatment, forced vital capacity, gallium uptake, and bronchoalveolar lavage percent lymphocytes;in Grassi C, Rizzato G, Pozzi E (eds): Sarcoidosis and Other Granulomatous Disorders. Amsterdam, Elsevier, 1988, pp 581-583.
6. Kuhn C 3rd, Boldt J, King TE Jr, Crouch E, Vartio T, McDonald JA: An immunohistochemical study of architectural remodeling and connective tissue synthesis in pulmonary fibrosis. Am Rev Respir Dis 1989;140:1693-1703.
7. Nakstad B, Lyberg T, Skjonsberg OH, Boye NP: Local activation of the coagulation and fibrinolysis systems in lung disease. Thromb Res 1990;57:827-838.
8. Fujimoto H, Gabazza EC, Hataji O, Yuda H, D'Alessandro-Gabazza CN, Nakano M, Franco OE, Hayashi T, Suzuki K, Adachi Y, Taguchi O: Thrombin-activatable fibrinolysis inhibitor and protein C inhibitor in interstitial lung disease. Am J Respir Crit Care Med 2003;167:1687-1694.
9. Rowland FN, Donovan MJ, Picciano PT, Wilner GD, Kreutzer DL: Fibrin-mediated vascular injury. Identification of fibrin peptides that mediate endothelial cell retraction. J Pathol 1984;117:418-428.
10. Senior RM, Skogen WF, Griffin GL, Wilner GD: Effects of fibrinogen derivatives upon the inflammatory response. Studies with human fibrinopeptide B. J Clin Invest 1986;77:1014-1019.
11. Olman MA, Hagood JS, Simmons WL, Fuller GM, Vinson C, White KE: Fibrin fragment induction of plasminogen activator inhibitor transcription is mediated by activator protein-1 through a highly conserved element. Blood 1999;94:2029-2038.
12. Hillyard CJ, Blake AS, Wilson K, Rylatt DB, Miles S, Bunch R, Elms MJ, Barnes A, Bundesen PG: A latex agglutination assay for D dimer: evaluation and application to the diagnosis of thrombotic disease. Clin Chem 1987;33:1837-1840.
13. Perez RL, Duncan A, Hunter RL, Staton GW Jr: Elevated D dimer in the lungs and blood of patients with sarcoidosis. Chest 1993;103:1100-1106.
14. Shorr AF, Hnatiuk OW: Circulation D dimer in patients with sarcoidosis. Chest 2000;117:1012-1016.
15. Anonymous: Standardization of spirometry - 1987 update. Statement of the American Thoracic Society. Am Rev Respir Dis 1987;136:1285-1298.
16. Colvin RB: Fibrinogen-fibrin interactions with fibroblasts and macrophages. Ann NY Acad Sci 1983;408:621-633.
17. Clark RAF, Lanigan JM, DellaPelle P, Manseau E, Dvorak HF, Colvin RB: Fibronectin and fibrin provide a provisional matrix for epidermal cell migration during wound reepithelialization. J Invest Dermatol 1982;79:264-269.
18. Olman MA, Mackman N, Gladson CL, Moser KM, Loskutoff DJ: Changes in procoagulant and fibrinolytic gene expression during bleomycin-induced lung injury in the mouse. J Clin Invest 1995;96:1621-1630.
19. Eitzman DT, McCoy RD, Zheng X, Fay WP, Shen T, Ginsburg D, Simon RH: Bleomycin-induced pulmonary fibrosis in transgenic mice that either lack or overexpress the murine plasminogen activator inhibitor-1 gene. J Clin Invest 1996;97:232-237.
20. Gunther A, Mosavi P, Ruppert C, Heinemann S, Temmesfeld B, Velcovsky HG, Morr H, Grimminger F, Walmrath D, Seeger W: Enhanced tissue factor pathway activity and fibrin turnover in the alveolar compartment of patients with interstitial lung disease. Thromb Haemost 2000;83:853-860.
21. Keller AZ: Hospital, age, racial, occupational, geographical, clinical, and survivorship characteristics in the epidemiology of sarcoidosis. Am J Epidemiol 1971;94:222-230.
22. Nagai S, Izumi T: Pulmonary sarcoidosis: population differences and pathophysiology. South Med J 1995;88:1001-1010.
23. Rybicki BA, Major M, Popovich J Jr, Maliarik MJ, Iannuzzi MC: Racial differences in sarcoidosis incidence: a 5-year study in a health maintenance organization. Am J Epidemiol 1997;145:234-241.
24. Gaines KJ, Chesney C, Zwaag RV, Cape C: Racial differences in coagulation studies in stroke. Neurol Res 1992;14(suppl 2):103-108.
25. Currie MS, Rao MK, Blazer DG, Cohen HJ: Age and functional correlations of markers of coagulation and inflammation in the elderly: functional implications of elevated crosslinked fibrin degradation products (D-dimers). J Am Geriatr Soc 1994;42:738-742.
26. Pieper CF, Rao KM, Currie MS, Harris TB, Chen HJ: Age, functional status, and racial differences in plasma D-dimer levels in community-dwelling elderly persons. J Gerontol A Biol Sci Med Sci 2000;55:649-657.
27. Conlan MG, Folsom AR, Finch A, Davis CE, Sorlie P, Marcucci G, Wu KK: Associations of factor VIII and von Willebrand factor with age, race, sex, and risk factors for atherosclerosis. The Atherosclerosis Risk in Communities (ARIC) Study. Thromb Haemost 1993;70:380-385.
28. Nguyen MD, Simpson-Haidaris PJ: Cell type-specific regulation of fibrinogen expression in lung epithelial cells by dexamethasone and interleukin-1beta. Am J Respir Cell Mol Biol 2000;22:209-217.
29. Balleisen L, Assmann G, Bailey J, Epping PH, Schulte H, van de Loo J: Epidemiological study on factor VII, factor VIII and fibrinogen in an industrial population. 1. Baseline data on the relation to age, gender, body-weight, smoking, alcohol, pill-using, and menopause. Thromb Haemost 1985;54:475-479.
30. Lee AJ, Fowkes GR, Lowe GD, Rumley A: Determinants of fibrin D-dimer in the Edinburgh Artery Study. Arterioscler Thromb Vasc Biol 1995;15:1094-1097.
31. van den Burg PJ, Hospers JE, Mosterd WL, Bouma BN, Huisveld IA: Aging, physical conditioning, and exercise-induced changes in hemostatic factors and reaction products. J Appl Physiol 2000;88:1558-1564.
32. Yarnell JW, Sweetnam PM, Rumley A, Lowe GD: Lifestyle factors and coagulation activation markers: the Caerphilly Study. Blood Coagul Fibrinolysis 2001;12:721-728.
33. Fisher SD, Zareba W, Moss AJ, Marder VJ, Sparks CE, Hochman J, Liang C, Krone RJ, THROMBO Investigators: Effect of smoking on lipid and thrombogenic factors two months after acute myocardial infarction. Am J Cardiol 2000;86:813-818.
34. Kimura S, Nishinaga M, Ozawa T, Shimada K: Thrombin generation as an acute effect of cigarette smoking. Am Heart J 1994;128:7-11.
35. Scarabin PY, Vissac AM, Kirzin JM, Bourgeat P, Amiral J, Agher R, Guize L: Elevated plasma fibrinogen and increased fibrin turnover among healthy women who both smoke and use low-dose oral contraceptives - a preliminary report. Thromb Haemost 1999;82:1112-1116.
36. Baughman RP, Teirstein AS, Judson MA, Rossman MD, Yaeger H Jr, Breznitz EA, the A Case Control Etiologic Study of Sarcoidosis (ACCESS) Research Group: Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med 2001;164:1885-1889.